KmPred: prediction of Michaelis constants (Km) using an integrative machine learning framework
On the MPEK dataset, the greatest model achieved a test MSE of 0.4995, RMSE of 0.7067, MAE of 0.5022, R<sup>2</sup> of 0.7049, and a PCC of 0.8398 (<i>p</i> < 1 × 10-6), outperforming the baseline MPEK model. On the Kroll dataset, KmPred achieved a test MSE of 0.6206, RMSE of 0.7878, R<sup>2</sup> of 0.5519, PCC of 0.7440, and Spearman's ρ of 0.7342, which represents reasonable results compared to state-of-the-art methods. These outcomes demonstrate that combining multi-modal protein sequence and ligand features with advanced machine learning architectures enables robust and generalizable Km prediction across diverse datasets. Specifically, we utilized LSTM and Transformer models solely for feature extraction to capture complex sequential and contextual patterns from enzyme sequences, while employing XGBoost as our primary regression model for final Km predictions. Beyond methodological impact, this work highlights the role of AI-driven kinetic modeling in accelerating enzyme characterization, facilitating metabolic engineering, and enhancing drug discovery pipelines. Our approach thus establishes a foundation for predictive enzymology at scale, with significant potential to benefit biotechnology, synthetic biology, and national strategic initiatives such as Saudi Vision 2030.
Authors
- Meshari Alazmi
Institutions
- Illinois College (US)
Publication Details
- Journal
- Frontiers in Artificial Intelligence
- Published
- 2026-01-30
- DOI
- https://doi.org/10.3389/frai.2026.1711471
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00